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ABSTRACT 
Background: Whether alcohol and cannabis complement or substitute each other has been studied for over two 
decades. In the changing cannabis policy landscape, debates are moving rapidly and spill over effects on other 
substances are of interest.  
Aims: update and extend a previous systematic review, by; a) identifying new human behavioural studies 
reporting on substitution and/or complementarity of alcohol and cannabis, and b) additionally including animal 
studies 
Methods: We replicated the search strategy of an earlier systematic review, supplemented with a new search 
for animal studies. Search results were crossed checked against the earlier review and reference lists were hand 
searched. Findings were synthesised using a narrative synthesis. 
Results: Sixty-five articles were included (64 in humans, one in animals). We synthesised findings into categories: 
patterns of use, substitution practices, economic relationship, substance use disorders, policy evaluation, others 
and animal studies. Overall, 30 studies found evidence for substitution, 17 for complementarity, 14 did not find 
evidence for either, and four found evidence for both.  
Conclusions: Overall the evidence regarding complementarity and substitution of cannabis and alcohol is mixed. 
We identified stronger support for substitution than complementarity, though evidence indicates different 
effects in different populations and to some extent across different study designs. The quality of studies varied 
and few were designed specifically to address this question. Dedicated high quality research is warranted. 
Declaration of interest: SB works at the Institute of Alcohol Studies which receives funding from the Alliance 
House Foundation. The other authors have no conflict of interest to declare.  
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BACKGROUND 
One aspect of the increasing liberalisation of medicinal and recreational cannabis taking place 
in many jurisdictions worldwide that remains poorly understood is the impact that potential 
increases in cannabis use will have on alcohol use, and whether alcohol and cannabis use 
substitute or complement one another. Substitution refers to the act of using something 
instead of another thing, and a complement is something which combines well with or 
improved something else.  
A prominent argument in this issue is whether full or partial legalisation of cannabis will have 
beneficial or harmful effects on the population. Pro legalisation groups have highlighted the 
benefits of increased tax revenue, lower law enforcement costs, and the possible medical 
benefits of cannabinoids for the treatment of certain diseases (McGinty et al., 2017; Sznitman 
and Bretteville-Jensen, 2015). Contrarily, groups that favour criminalization argue on the 
harms caused to youth due to increased availability, increased motor vehicle accidents, and 
are sometimes also sceptical of the possible medical benefits (McGinty et al., 2017; Sznitman 
and Bretteville-Jensen, 2015). 
A key component of the debate has been the harms due to these substances. By 2015, 63.5 
million people where estimated to have alcohol use disorder worldwide, and 19.8 million 
cases of cannabis use disorder where estimated (Degenhardt et al., 2013; Peacock et al., 
2018). Alcohol has been ranked as one of the most harmful psychoactive substances, and has 
been linked to a number of acute and chronic health harms such as cancer and cirrhosis, and 
is correlated with harms to others, as well as social and economic consequences (Nutt et al., 
2010; Van Amsterdam et al., 2010). Some rank cannabis as a medium to low risk substance 
(Nutt et al., 2010; Van Amsterdam et al., 2010). However, research throughout the past 
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twenty years has evidenced that regular cannabis use is correlated to significant health and 
psychosocial harms, and has been linked to poorer school performance, psychosis and 
cognitive impairment in adulthood, and cardiovascular disease among vulnerable individuals 
(Hall, 2015). 
Several reviews have looked at the relationship between cannabis and alcohol. While some 
have found evidence of increased co-use of cannabis and other substances upon cannabis 
liberalisation, they also concluded further research was needed on this subject (Yurasek et 
al., 2017). The current changing legal landscape has brought this debate to the forefront with 
some US states, Canada, and Uruguay, legalising recreational cannabis. Therefore, it is 
urgently pressing to better understand the relationship between alcohol and cannabis. 
The present study is an update and extension of a systematic review completed by 
Subbaraman (2016), which concluded that alcohol and cannabis act as both complements and 
substitutes (Subbaraman, 2016). Given the rapidly changing policy landscape, a number of 
studies have been published since the previous was published. In the present study, we 
update and expand on the previous review on substitution and complementarity of alcohol 
and cannabis by identifying new behavioural studies in humans and adding a systematic 
review of experimental animal studies. 
 
METHODS 
PRISMA-P 2015 Guidelines were used to report findings from this study. 
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Search Strategy 
MEDLINE, PsychINFO, and Embase were searched through OVID on the 28th of May 2018 
replicating the search strategy of Subbaraman’s 2016 review. The ISI Web of Science (WoS) 
was also searched using the Web of Science Core Collection. Additionally, articles found 
through hand searching reference lists on other sources that were found to be relevant were 
also included. Search terms were used as key words in the title and/or abstract, or as Medical 
Subject Heading Terms. The search terms used in OVID “alcohol.mp” OR “exp ALCOHOLS” 
AND “cannabis.mp” OR “exp CANNABIS” AND “complement*.tw” OR “substitut*.tw”. For the 
ISI WoS, the search terms used where screened across titles and abstracts and where the 
following, “alcohol” OR “ethanol” AND “cannabis” OR “mari?uana” AND “complement*” OR 
“substitut*” 
For the additional review of animal studies, MEDLINE, PsychINFO, and Embase were searched 
through OVID on the 20th of May 2018. The search was performed simultaneously through 
the three databases. The search terms used were chosen because of their similarity to the 
ones used in the update of the Subbaraman review. The terms “complement” and 
“substitute” were not included. The search terms were filtered for title and abstract. The 
search strategy used in Ovid was “alcohol.tw” OR “ethanol.tw” AND “cannabis.tw” OR 
“mari?uana.tw” and filters were used to limit the results to animal studies. 
Additional records identified through hand searching and through expert recommendations 
were also included. 
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Inclusion Criteria 
In this systematic review, the inclusion criteria were the same as the Subbaraman (2016) 
review; (1) they had to be behavioural studies, (2) with a human population, and (3) if the 
independent variable was cannabis related, the dependent variable had to be alcohol related, 
or vice versa. For the animal studies, studies were eligible for inclusion if (1) they were 
experimental studies, (2) had an animal population, and (3) if the independent variable was 
cannabis-related, the dependent-variable had to be alcohol related, or vice versa. 
 
Data selection 
All results were exported into Refworks ProQuest. Titles and abstracts were screened 
independently by two reviewers to assess eligibility for inclusion. The data extracted was; (a) 
country, (1) study design, (2) population, (3) sample size, (4) type of measure, (5) 
measurement tool, (6) independent variable, (7) dependent variable, (8) statistical analysis, 
(9) control variables, (10) conclusion (substitution, complementarity, both, or neither), and 
(11) quality assessment. The data was extracted into a data extraction template in Microsoft 
Excel. 
 
Quality Assessment 
Quantitative studies were assessed using the Effective Public Health Practice Project Quality 
Assessment Tool for Quantitative Studies (EPHPP), as recommended in the Cochrane 
Handbook (Higgins and Green, 2011). However, the tool does not address individual 
limitations for each study, thus independent qualitative assessment was additionally 
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conducted by the reviewers to better assess the quality. Qualitative studies were assessed 
using the Critical Appraisal Skills Programme Checklist for Qualitative Studies (CASP). Animal 
studies were assessed using the SYRCLE’s Risk of Bias tool for Animal Studies (Hooijmans et 
al., 2014). 
 
Narrative Synthesis of Study Findings 
Due to the broad inclusion criteria in terms of study design and population, a meta-analysis 
was not feasible, and a narrative synthesis was more appropriate (Cheung and Vijayakumar, 
2016; Jahan et al., 2016).  
Findings were synthesised narratively under seven topics. Patterns of use; studies analysing 
how different populations use alcohol and cannabis in their daily life. Substitution practices; 
studies exclusively exploring self-reported substitution of cannabis for alcohol or alcohol for 
cannabis in specific populations. Economic relationship; Studies that evaluate if a monetary-
related change in one substance affects the use or demand of another substance. Substance 
use disorders; studies evaluating changes in substance use in a population attempting to stop 
or reduce the use of another substance. Policy evaluation; studies that analyse the impact 
that a cannabis or alcohol related policy has in the use of alcohol or cannabis. Animal studies; 
experimental studies that analyse the relationship between alcohol and cannabis in animal 
models. Others; Studies that analyse substitution and complementarity between alcohol and 
cannabis but do not fit into any of the above-named groups 
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Terminology 
The word substitution and complementarity are used as shorthand throughout the article to 
describe the results of included studies. These terms are well suited to describing the majority 
of the individual-level data studies. However, they may be less adequate when addressing 
ecological studies which use population level data, where population level changes in alcohol 
or cannabis use do not necessarily reflect individuals switching from one substance to 
another, for example. However, for ease of understanding, and for consistency with the 
existing literature and search strategy, we use the same terminology for population-level 
studies. 
 
RESULTS 
Included studies 
In total, 1046 articles were identified [FIGURE 1]. In total, 65 articles were included in the final 
review. Of these, 39 are the papers found in the Subbaraman (2016) review, and 26 additional 
articles were included in this review. 
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General characteristics of the studies 
Studies included were published between 1970 and 2019. Studies were conducted in USA 
(n=49), Canada (n=4), Australia (n=5), Norway (n=2), UK (2), Brazil (n=1), Sweden (n=1), and 
one was conjointly conducted in USA, The Netherlands, and Canada. The sample sizes ranged 
from 8 to 5,428,399. Twenty-six longitudinal studies, 34 cross sectional studies, one 
randomised controlled trial (RCT), one secondary analysis of an RCT, one experimental study 
in animals, one qualitative study, and one economic analysis study were identified.  
Measures were also grouped into categories. The type of measure used was defined as the 
main unit or units of measurement explaining the dependent variable (outcome). Eight types 
of measure were identified (Table 1). 
 
 
Table 1. Types of measures 
Consumption Units of quantity and/or frequency of alcohol and/or cannabis, or participation in use 
measured by a dichotomous variable 
 
Toxicological Toxicological measures 
 
Self-reported use Self-report of cannabis and/or alcohol use 
 
Self-reported 
substitution 
Self-report of substituting one substance for another 
 
 
Fatalities Quantity of traffic fatalities and of cannabis positive drivers involved in traffic fatalities 
 
Monetary  Measures of drug prices 
 
Qualitative 
interview 
Reported through patient’s interviews. 
 
 
Locomotor activity Distance moved by mice. 
 
Unspecified Does not specify the unit of measure used 
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1. Policy evaluation studies  
This section contains ecological studies on changes in cannabis policy. “Substitution” and 
“complementarity” are used as shorthand to describe any changes in alcohol use which were 
measured on a population level. Where studies used individual level data, this is noted in the 
text. 
1.1 Minimum Legal Drinking Age (MLDA)  
Six studies looked at the effects of MLDA on cannabis and alcohol use, looking at the changes 
in substance use after a MLDA of 21 years had been applied in the USA. Two studies found 
evidence for substitution, one for complementarity, and three did not find evidence for 
either. Five studies used measures of consumption and one study used fatality measures. Four 
studies, and two were rated as moderate. 
Regarding substitution, one study conducted in the 1980s in 43 US States, found that 
increased legal drinking age was associated with reduced alcohol use, but increased cannabis 
use (DiNardo and Lemieux, 2001). Another study using data from the early 2000s found that 
turning 21 years, and thus having legal access to purchase and drink alcohol, was linked to 
decreased cannabis use but increased alcohol use (Crost and Guerrero, 2012). This study 
analysed consumption data from individuals just below and above 21 years of age, therefore 
it did not rely on cross sectional state variations in alcohol prices and policies. 
Contrarily, a study that used individual level data and also looked at cannabis and alcohol use 
just upon turning 21 years of age, found evidence for complementarity, with a 7% and 7.6% 
increase in cannabis and alcohol use respectively upon turning 21 in a MLDA-21 (Yörük and 
Yörük, 2011). Later on, the authors stated using a restricted sample in their original study, and 
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in a newer analysis found that in the full sample, the effect of the MLDA-21 was similar for 
alcohol but smaller and statistically insignificant for cannabis (Yörük and Yörük, 2013). 
 
1.2 Medical Marijuana Laws (MML)  
Six studies assessed the impact of new MMLs on alcohol use. Four concluded substitution, 
one concluded complementarity, and one did not conclude either of the two. Four studies 
used measures of consumption and two used traffic fatality measures. Two studies were rated 
as strong, three as moderate, and one as weak. 
Regarding substitution, a study looking at individual level data found that cannabis use and 
binge drinking decreased in 8th graders, but not in 10th and 12th graders, upon MML 
enactment, accounting for policies that could have affected the price of different substances 
(Cerda et al., 2018). Anderson (2013) conducted a study evaluating the impact of MMLs on 
traffic fatalities and alcohol use, and found that legalisation was associated with a decrease 
in alcohol involved traffic fatalities after a full the law came into effect (Anderson et al., 2013). 
Another study looked at border alcohol sales from Retail scanner data in 38 contiguous 
counties in Washington, and found that legalisation was associated with a 12% reduction in 
alcohol sales (Baggio et al., 2018). 
One study found weak evidence for complementarity, stating that MMLs were associated 
with increased frequency of binge drinking in adults (21+), but this finding was not seen in 
adolescents (Wen et al., 2014). This study used individual level substance use and binge 
drinking. 
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1.3 Cannabis and alcohol related policies  
Nine studies looked at cannabis related policies on alcohol and cannabis use. Seven studies 
found evidence for substitution and two for complementarity. Seven studies used 
consumption measures, one used a monetary measure, and one used fatality measures. 
Three studies were rated as strong, four as moderate, and two as weak. 
Regarding substitution, one study that used a survey to simulate cannabis legalization on 
Australian college students found a 4% increase in cannabis use and a 1-4% reduction in 
alcohol use (Clements and Daryal, 2005). Another study evaluated the impact of cannabis 
decriminalisation in 11 US states, in an all-male sample, and found weak evidence that fewer 
individuals drank “six or more drinks” on a single drinking occasion (Thies and Register, 1993). 
Another study compared one London borough (Lambeth), were small quantities of cannabis 
were depenalised, to other London boroughs and found that cannabis depenalisation was 
associated with a reduction in alcohol-related hospital admissions in 15-24 years old, but no 
effect in older adults (Kelly and Rasul, 2014). A study that followed a small regional sample of 
two cohorts of 8th grade students in Tacoma, Washington, looking at individual-level alcohol 
and marihuana use, found that the cohort that did not experienced recreational cannabis 
legalisation enactment had higher rates of cannabis use and the cohort that did experience 
the law enactment had higher rates of alcohol use (Mason et al., 2016). 
In a study comparing different countries it was found that stricter alcohol policies where 
associated with reduced alcohol use among 6th and 10th graders but did not find evidence of 
changes in cannabis use (Simons-Morton et al., 2010). Another study found an increase in the 
price of alcohol was associated with a reduced probability of cannabis use in the youngest 
cohort (15-20 years), analysing individual level past month cannabis use (Farrelly et al., 1999). 
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2. Substance use disorders studies  
2.1 Cannabis cessation or reduction  
Twelve studies were identified. Four studies found evidence for substitution, one for 
complementarity, one for both, and six for neither. Seven studies used consumption 
measures, one used self-reported use of substance, one used toxicological data, and three 
did not specify the measure. One study was rated as strong, six as moderate, and five as weak.  
Studies that found evidence for substitution were all conducted on non-treatment seeking 
cannabis users reducing their use (Allsop et al., 2014; Copersino et al., 2006a, 2006b; Peters 
and Hughes, 2010). One study found a 52% increase of alcohol use at follow-up (alcohol 
drinks/day), among participants with former alcohol abuse/dependence problems, when they 
abstained from cannabis use (Peters and Hughes, 2010). Another study identified a greater 
increase of alcohol use during cannabis abstinence among baseline light drinkers (21 Standard 
Units/week), compared to those who were heavier drinkers at baseline (Allsop et al., 2014).  
 
2.2 Alcohol cessation or reduction  
Five studies were identified. One study found evidence for substitution and two studies 
concluded on complementarity and two did not conclude on neither. Four studies used 
measures of consumption measures and one used self-report use. Two were rated as 
moderate, and three as weak. 
Regarding substitution, one study looked at records of 92 patients that reported using 
cannabis to treat their alcohol use problems and found that 83 patients reported cannabis as 
15 
 
effective, while nine said to use cannabis to achieve total abstinence (Mikuriya, 2004). As to 
complementarity, one study found that participants who used cannabis at post discharge 
from alcohol dependence treatment were associated with a higher risk of relapsing and 
returning to alcohol use (Aharonovich et al., 2005).  
 
3. Economic relationship  
3.1 General population  
Three studies were included in this group. One study concluded complementarity, and two 
studies found evidence for both complementarity and substitution. All studies used 
consumption measures and were rated as strong. 
Comparing cross price effects in eight demographic samples, one study found that alcohol 
and cannabis were associated as economic complements in the full sample, in white-male-
non-Hispanics, in blacks, and in Native Americans (Saffer and Chaloupka, 1999a). This study 
also found evidence of substitution in Hispanics, and no effect in women, Asians, and young 
people (Saffer and Chaloupka, 1999a).  
A study conducted in Australia found that a 10% increase in the price of alcohol could be 
related to a 4.17% increase in the probability of cannabis use, suggesting economic 
substitution (Cameron and Williams, 2001). They also found that cannabis decriminalisation, 
as an indicator of price, could increase alcohol participation, suggesting complementarity 
(Cameron and Williams, 2001). In South Australia, the only state that decriminalised cannabis, 
individual-level alcohol drinking was 3% higher than in the rest of the country (Cameron and 
Williams, 2001). 
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3.2 Young people  
Two studies found evidence for complementarity, one for substitution, and one for both. All 
used measures of consumption and were rated as strong. 
Regarding complementarity, a study from the USA among 14-21-year olds found that 
doubling beer tax could result in a 11.4% reduction in the probability of using marijuana and 
a 13.3% reduction in the demand for marijuana, compared to a 3.2% reduction in the 
probability of using alcohol and an 8.1% reduction in the demand for alcohol (Pacula, 1998).  
Another study on college students found that higher beer tax was associated with lower 
prevalence of alcohol and cannabis use, and cannabis prices were negatively related to 
alcohol and marijuana participation (Williams et al., 2004). Results from Williams (2004) are 
difficult to weight as the tool used (CAS) is nationally representative of fulltime students in 
four-year colleges only, and provides self-reported data. Both studies rely on cross sectional 
data and price policies (Pacula, 1998; Williams et al., 2004). 
A study from the 1980s that used decriminalisation as an indicator of cannabis price (cannabis 
in decriminalised states is expected to be cheaper) found that youth consumed alcohol less 
frequently and were less likely to engage in heavy drinking in decriminalized states 
(Chaloupka and Laixuthai, 1997). Furthermore, they found that a state that moved from 
criminalisation to decriminalisation, the number of drinking abstainers could increase by 12%, 
frequent drinkers could reduce by 11%, and heavy drinking episode could reduce by 12% 
(Chaloupka and Laixuthai, 1997). In a sample of 12th graders, one study found that a 1% 
increase in liquor prices was associated with reduced odds of frequent marijuana use by 2.4% 
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(complementarity), but decriminalisation of marijuana was linked to reduced odds of 
frequent drinking by 7% (substitution) (Yamada et al., 1996). 
 
3.3 Drug users  
Of the two studies, one concluded on substitution and one on complementarity. One study 
used measures of consumption, and the other used monetary measures. One study was rated 
as strong, and the other as weak. 
A study on a sample of 80 polydrug users found an increase in alcohol purchases when the 
perceived quality of cannabis dropped to average or poor (Cole et al., 2008).   
A study in Australia found evidence for complementarity showing that the price of alcohol 
and the fine for exceeding the Blood Alcohol Concentration limit for driving was negatively 
related to cannabis use. This was stronger in participants that used alcohol and cannabis 
concomitantly (Williams and Mahmoudi, 2004). 
 
3.4 Other  
This study analysed the changes in cannabis prices in Australia and found that, for the period 
of 1990, cannabis prices dropped an average of 20 percent, while cannabis consumption 
increased 2,8 percent and alcohol consumption dropped an average of 6,05 percent, 
supporting substitution (Clements, 2004). 
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4. Patterns of use  
4.1 General population  
This study found evidence for complementarity, used consumption measures, and was rated 
as moderate. The study compared the use and transition of substances in different types of 
cannabis users, in two periods of time, and found that participants who continued to use 
cannabis from Wave 1 to Wave 2 had higher odds of reporting alcohol use problems, 
compared to participants who stopped using cannabis (Choi et al., 2018). 
 
4.2 Young people  
Four studies found evidence for complementarity, and one found evidence for neither. All 
studies used consumption measures. One study was rated as strong, one as moderate, and 
three as weak. 
A Norwegian study on high school students found that those who drank more alcohol were 
more likely to use both substances, and that in 80% of cannabis events, drinking had also 
occurred (Pape et al., 2009). An earlier Norwegian study found that regular cannabis users 
showed greater alcohol use, compared to those who only tried cannabis occasionally 
(Hammer and Vaglum, 1992). A study that assessed a cohort of college students in the USA 
found that one more drink in the month duration of the study was associated with 40% 
increased odds of using cannabis (O’Hara et al., 2016).  
 
5. Substitution practices  
5.1 Medical cannabis patients  
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All studies found evidence of substitution. All studies used self-reported substitution as the 
main measure unit and were rated as weak. 
 The three studies conducted in Canada were funded by the dispensaries whose costumers 
made up the study populations, and found a 25%, 52%, and 41% substitution rate of medical 
cannabis for alcohol (Lucas et al., 2013, 2016; Lucas and Walsh, 2017). Another study was 
conducted across three dispensaries in USA and found that 42% of participants reported a 
reduction in alcohol use since they started using medical cannabis (Piper et al., 2017). The last 
study was conducted in the USA and found that 40% of the participants reported substituting 
alcohol for cannabis. 
 
5.2 Cannabis users  
This was the only qualitative study identified in the review. The conclusion was substitution. 
Participants reported that they substituted alcohol for cannabis because it was “safer” and 
had less adverse effects. 
 
6. Other  
Studies in this category did not fit within the other categories for the narrative synthesis. Two 
studies concluded substitution and two concluded complementarity. Three studies used 
consumption measures and one used self-reported substitution. One study was rated as 
strong, one as moderate, and two as weak. 
Considering substitution, one study found that participants who reported no alcohol use were 
more likely to report cannabis use (Alter et al., 2006). Another study used a sub sample of 
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(Reiman, 2009), and found that 50% of participants reported substituting alcohol for cannabis 
(Reiman, 2007). 
Regarding complementarity, one study analysing the impact of Methadone Maintenance 
Therapy (MMT) enrolment on the onset of heavy drinking, in injectable heroin users, found 
that cannabis use was related to heavy drinking onset, and not MMT (Klimas et al., 2016). 
Another study from the USA found that there were twice as many Simultaneous Users (using 
cannabis and alcohol concomitantly) as there were Concurrent Users (cannabis and alcohol 
use separately), and simultaneous users had higher levels of frequency and quantity of 
alcohol use, and had higher likelihood of drunk driving (Subbaraman and Kerr, 2015). 
 
7. Animal studies  
This study was conducted on a rodent model exploring the roll of cannabinoids in alcohol 
related problems using locomotor activity as the main unit of measurement. The study was 
rated with low risk of bias. It used a twelve-day acquisition period of daily ethanol injections, 
followed by four-days of injections of cannabinoid treatment, and found that THC or THC + 
CBD was effective at reducing alcohol sensitisation, but CBD alone was not effective (Filev et 
al., 2017). 
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DISCUSSION 
Sixty-five eligible articles were identified and included in this review. Thirty studies found 
evidence for substitution, 17 for complementarity, four found evidence for both, and 14 did 
not find evidence for either. Overall, the conclusions of this review and Subbaraman (2016) 
are very similar. However, whereas Subbaraman (2016) found that decriminalisation suggests 
some evidence of substitution, this review found mixed evidence for cannabis 
decriminalisation, depending on the population being studied. Our findings were synthesised 
into seven groups in a narrative synthesis. This showed that the evidence differs based on the 
population studied, on the type of study, and the quality of data. 
 
Main results 
The largest number of studies were on alcohol and cannabis related policies. This review 
found that in MML-jurisdictions, there is some evidence of a substitution effect among 
adolescents, which is similar to a review by Schlienz and Lee (2018). Other types of cannabis 
policies showed mixed findings. The evidence on the impact of alcohol related policies was 
inconclusive. However, there are studies that show that increasing the price of alcohol can 
result in a reduction of both, alcohol and cannabis use in adolescents. Overall, we find that a 
large number of policy studies address individual policies and are limited to cross sectional 
data and self-reported surveys, which makes analysis of results difficult as evidence may not 
be sufficiently strong. 
Substitution of one substance for another has been a major concern among clinicians. One 
study found that even though the prevalence of co-use of alcohol and cannabis is high among 
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people in drug treatment, the literature does not show clear direction of substitution or 
complementarity (Yurasek et al., 2017). However, an interesting finding is that the few studies 
that show increased drinking during cannabis abstinence were all conducted on cannabis-
users who were not seeking treatment, while those that showed evidence of reduced drinking 
during cannabis abstinence were all conducted on users who were seeking treatment. This 
shows there may be wider factors to additionally consider, such as motivation to stop 
substance use. 
Regarding how cannabis and alcohol relate to each other economically, the findings were less 
consistent. Some studies suggested young people were more responsive to increased alcohol 
prices, compared to cannabis prices, given that two studies show that increased beer tax 
reduced alcohol and cannabis use in college students. Nevertheless, these studies are limited 
to cross sectional data and self-reported surveys, which could be highly biased. 
There was some evidence that medical cannabis patients use cannabis to substitute alcohol. 
Still, these findings must be interpreted with caution, as most of these studies were funded 
by the same medical cannabis dispensaries who provided the cannabis to the study 
participants. These studies also did not assess complementarity, and therefore, the risk of 
bias is high in this group of studies. 
Only one study in animals was identified. This study showed evidence of potential for 
cannabinoids in the treatment for alcohol use disorders, either in managing alcohol 
withdrawal or for relapse prevention. 
This review has several strengths. Firstly, the quantity of papers included provides a large 
body of evidence which allows to expand our understanding as well as identifying gaps in the 
literature. Following the search strategy of the previous systematic review replicates and 
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expands on its findings. The addition of quality assessment tools provides more nuance of the 
studies included in this review, which allows for a greater understanding of the issue and 
highlights where more high-quality research is needed. The review of animal studies adds a 
new perspective to the debate and highlights potential medical benefits of cannabinoids in 
the treatment of alcohol use disorders. Finally, using a narrative synthesis of study allows for 
findings to be differentiated based on study design is another strength of the study as it may 
be the case that cannabis can be a substitute in some instances and a complement in others. 
We also identified several limitations. First, most studies have been conducted on the impact 
of policies, leaving large gaps of evidence in other areas. Also, a large portion of the studies 
were assessed as weak, thus, much of the evidence is based on poor quality studies, making 
it difficult to draw strong conclusions. All studies on medical cannabis patients were found 
weak to be weak with a high likelihood of bias, thus providing little reliable evidence. Most 
studies also used self-report measures, which are known to be biased and somewhat less 
reliable. Some of the studies did not clearly state how they measured outcomes, making 
comparison to other studies difficult. Lastly, many studies have shown the potency of 
cannabis has drastically increased over the last few decades, which may lead different results 
between newer and older studies (Chandra et al., 2019; Freeman et al., 2019). 
We identified a number of newer studies (17) published since the previous review, suggesting 
that ongoing monitoring of the literature would be of value. The evidence base may evolve 
as interest grows in this area and more studies are published. Comprehensive research of 
drug policy implementation across different populations should be subject of future studies. 
The recent enactment of cannabis legalisation in Canada will provide a natural experiment to 
24 
 
evaluate the changes in cannabis and alcohol use. Research into clinical populations is 
inconclusive with overall study quality being low.  
Evidence from animal studies is recent and scarce and no early conclusions should be drawn. 
Also, these findings are difficult to generalise to humans as results from animal studies are 
often not replicated in humans.  
Finally, most studies were conducted in the USA. Research is needed in other jurisdictions to 
study how findings vary in systems that differ politically, economically and culturally.  
 
CONCLUSION 
This review found evidence for both, substitution and complementarity, between cannabis 
and alcohol. Across the different groups assessed in this review, we find that the largest 
amount of research has been conducted on policy studies substitution, with evidence leaning 
towards substitution. Otherwise, findings do not show a clear tendency to either substitution 
or complementarity, and suggest that alcohol and cannabis are used differently and have 
different effects in different populations. Moreover, to our knowledge, this is the first review 
that explores the effects of alcohol and cannabis use in animal models, with some novel 
findings. We find the evidence base on this topic expanding rapidly. Overall, there is a need 
of high-quality research designed to address the topic, for example, through experimental 
studies and capitalising opportunities to conduct ecological studies as a result of the current 
rapidly changing policy landscape around cannabis in some parts of the world. 
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Table 2. Policy Evaluation Studies (20 studies) 
 
Paper Country Study design Population Sample size Measure 
Category 
Measurement 
tool 
Independent 
variable 
Dependent variable Conclusion Quality 
assessment 
 
Medical Marijuana Laws studies (7 studies) 
 
 
Baggio, 2018 
(Baggio et al., 
2018)  
USA Pre/post Nielsen 
Retail 
Scanner 
database 
2006-2015 
 
52 market 
areas in 48 
contiguous 
states 
 
Consumption Nielsen Retail 
Scanner 
database 
 
County-level 
MML 
County-level alcohol 
sales 
Substitution Moderate 
Cerda, 2018 
(Cerda et al., 
2018)  
USA Pre/post MTF 1991-
2015 
1,179,372 Consumption Monitoring The 
Future Data 
State-level MML Individual-level past 
30-day cannabis use, 
and past two-week 
binge drinking 
 
Substitution Weak 
Sabia, 2017 
(Sabia et al., 
2017) 
USA Repeated 
cross 
sectional 
Behavioral 
RISK Factor 
Surveillance 
System 
1990-2012 
population 
 
5,428,399 
 
Consumption Behavioral 
Risk Factor 
Surveillance 
System 
State-level MML Past 30-day alcohol 
consumption 
Substitution Moderate 
           
Salomonsen-
Sautel, 2014 
(Salomonsen-
Sautel et al., 
2014) 
USA Longitudinal 
Pre/post 
Fatality 
Analysis 
Reporting 
System 
(FARS) 
36-six-month 
intervals of 
motor vehicle 
fatalities 
Fatality FARS Indicator of 
commercial 
availability of 
medical cannabis 
in Colorado 
(2009) 
State-level 
proportions of 
drivers in fatal 
crashes who were 
alcohol-impaired or 
cannabis-positive 
Neither Strong 
26 
 
 
Wen, 2014 
(Wen et al., 
2014)  
USA Cross 
sectional 
Survey 
National 
Survey on 
Drug use and 
Health 
183.600 (12-
20), 219.400 
(20+) 
Consumption National Survey 
on Drug Use 
and Health 
(NSDUH) 
 
State-level MML 
indicator 
Individual-level 
alcohol, cannabis, 
and other drug use, 
binge-drinking 
Weak 
complements 
among those 
older than 21 
Moderate  
Anderson, 
2013  
(Anderson et 
al., 2013) 
USA Longitudinal 
Pre/post 
National 
Survey on 
Drug Use 
and Health 
(NSDUH) and 
FARS BRFSS 
 
Varies by 
dataset 
Fatality NSDUH, High 
Price Magazine, 
FARS 
State-level MML 
& cannabis 
decriminalisation 
indicators 
State-level alcohol-
related traffic 
fatality rate, 
monthly # drinks, 
prevalence of 
bingeing 
Substitutes Strong 
 
Cannabis and alcohol related policies studies (7 studies) 
 
           
Subbaraman, 
2019 
(Subbaraman 
and Kerr, 
2019)  
USA Cross 
sectional 
survey 
Washington 
residents 
aged 18 and 
over 
5492 Consumption Self-report 
survey 
Legalisation of 
recreational 
cannabis 
Individual-level past 
30 days number of 
drinking days, 
number of drinks 
per drinking day, 
frequency of 5 or 
more drinks, alcohol 
related harms 
 
Some evidence 
of substitution 
for (decrease 
in alcohol 
related harms) 
Strong 
Miller, 2018 
(Miller and 
Seo, 2018) 
USA Longitudinal Nielsen 
Retail 
Scanner 
database 
 
37 
Washington 
counties 
 
Monetary Nielsen Retail 
Scanner 
Dataset 
State-level 
marihuana 
legalisation 
 
State-level alcohol 
sales 
Substitution Moderate 
Mason, 2016 
(Mason et al., 
2016)  
USA Cohort Adolescents 
in 
Washington 
(two cohorts, 
before and 
238 Consumption Self-report 
surveys 
State-
level pre/post 
non-recreational 
marijuana law 
Individual-level past 
30 days rate of 
alcohol, marijuana 
and cigarette use 
Substitution Moderate 
27 
 
after non-
recreational  
marijuana 
law) 
 
Kelly, 2014 
(Kelly and 
Rasul, 2014)   
UK Pre/post Quarterly 
hospital 
admissions 
from 1997-
2009 in 
London, 
England 
 
<1 million 
public hospital 
admissions 
Fatality Hospital 
records 
Depenalisation of 
cannabis 
possession in 
Lambeth, London, 
England 
Hospitalizations 
related to alcohol 
use 
Substitutes Strong 
Simons-
Morton, 2010 
(Simons-
Morton et al., 
2010)  
Canada, 
USA, 
Netherlands 
Cross 
sectional 
Survey 
Health 
Behaviour in 
School Age 
Children (15 
years old) 
 
4858 Consumption Health 
Behaviour in 
School-Aged 
Children Survey 
(HBSC) 
Restrictiveness of 
country-level 
alcohol and 
cannabis prices 
Country-level 
frequency alcohol, 
cannabis use 
Complement Strong 
Clements, 
2005  
 
Australia Cross 
sectional 
survey 
First year 
college 
economics 
students 
 
281 Consumption Self-report 
survey 
Hypothetical 
(simulation) 
cannabis 
legalisation 
Individual-level 
beverage specific 
alcohol use 
Substitution Weak 
Farrelly, 1999 
(Farrelly et al., 
1999)   
USA Cross 
sectional 
survey 
National 
Household 
Survey on 
Drug Abuse 
(12-20 years 
old) 
49,311 Consumption National 
Household 
Survey on Drug 
Abuse (NHSDA) 
 
State-level 
cannabis 
penalties, county-
level # cannabis 
arrests 
Individual-level past 
month cannabis use 
Complement Moderate  
Thies, 1993 
(Thies and 
Register, 
1993)  
USA Cross 
sectional 
Survey 
National 
Longitudinal 
Survey of 
Youth (1979) 
12,686 Consumption National 
Longitudinal 
Survey of Youth 
(1984 and 
1988) 
 
State-level 
cannabis 
decriminalisation 
indicator, MLDA 
arrests 
Individual-level 
cannabis and alcohol 
use and frequency 
Weak 
substitutes 
Moderate  
28 
 
McGlothlin, 
1970 
(Mcglothlin et 
al., 1970) 
 
 
USA Cross 
sectional 
survey 
College 
students and 
free clinic 
patients 
594 Consumption Self-report 
survey 
Occurrence of 
operation 
intercept (1969) 
(Marijuana 
blockage)  
Prevalence of self-
reported 
substitution of 
alcohol for cannabis 
Substitution Weak 
 
Minimum Legal Drinking Age studies (6 studies) 
 
Keyes, 2015 
(Keyes et al., 
2015) 
USA Pooled cross 
sections 
15-25-year 
olds from 
the 1999-
2011 FARS 
7191 Fatality FARS Turning MLDA of 
21 
Individual-level fatal 
injury due to alcohol 
use, marijuana use, 
or alcohol and 
marijuana use 
 
Neither Moderate 
Krauss, 2015 
(Krauss et al., 
2015) 
USA Cross 
sectional 
Survey 
NSDUH 
2004-2012 
(Born 1949-
1972) 
110,300 Consumption National Survey 
on Drug Use 
and Health 
State-level MLDA-
21 
Individual-level past 
month and past year 
cannabis use and 
meeting criteria for 
marijuana 
abuse/dependence 
 
Neither Strong 
Crost, 2013 
(Crost and 
Rees, 2013) 
USA Cross 
sectional 
panel survey 
National 
Longitudinal 
Survey of 
Youth 
 
28,089 Consumption National 
Longitudinal 
Survey of Youth 
(1997) 
Turning MLDA of 
21 
Individual level past 
30-day cannabis use 
and frequency 
 
Neither Strong 
Yoruk, 2013 
(Yörük and 
Yörük, 2013) 
USA Cross 
sectional 
survey 
National 
Longitudinal 
Survey of 
Youth (1997) 
~9000 Consumption National 
Longitudinal 
Survey of Youth 
(1997) 
Turning MLDA of 
21 
Individual-level past 
30-day cannabis and 
alcohol use and 
frequency 
 
Neither Moderate 
           
Crost, 2012 
(Crost and 
USA Cross 
sectional 
Survey 
National 
Survey on 
71 (State-level 
observations) 
Consumption National Survey 
of Drug use and 
Health 
Turning MLDA of 
21 
Population level past 
month cannabis and 
alcohol frequency 
Substitution Strong 
29 
 
Guerrero, 
2012)    
Drug Use 
and Health 
 
 
           
DiNardo, 2001 
(DiNardo and 
Lemieux, 
2001)   
USA Cross 
sectional 
Survey 
Monitoring 
the Future 
Study 
>156,000 Consumption Monitoring the 
Future Data 
MLDA, State-level 
cannabis 
decriminalisation 
indicator, alcohol 
price 
State level 
prevalence of past 
day 30-day cannabis 
& alcohol frequency 
Substitution Strong 
Abbreviations for measurement tool: FARS (Fatality Analysis Reporting System) 
 
 
Table 3. Substance use disorders studies (17 studies) 
 
Paper 
 
 
Country 
 
 
Study design 
 
Population 
 
Sample 
size 
 
Measure 
Category 
 
 
Measurement 
tool 
 
Independent 
variable 
 
Dependent 
variable 
 
Conclusion 
 
Quality 
assessment 
 
Cannabis cessation or reduction studies (13 studies) 
 
Hodgins, 2017 
(Hodgins et 
al., 2017)   
Canada Cross 
sectional 
Survey 
Individuals recovered 
from Cannabis Use 
Disorder through 
treatment-assisted or 
self-directed efforts 
119 Consumption Marijuana 
Problem Scale, 
Process of Change 
Questionnaire, 
researcher-led 
interview on 
substance use 
changes during 
recovery 
 
Cannabis 
recovery 
(abstinence or 
moderation) 
Self-
reported 
changes in 
other 
alcohol use 
Both Weak 
Allsop, 2014 
(Allsop et al., 
2014)   
Australia Prospective 
community-
based cohort 
Non-treatment seeking 
cannabis users 
45 Consumption Cannabis 
withdrawal Scale 
(CWS) and 
urine toxicology 
Cannabis 
abstinence 
Quantity of 
alcohol use 
Substitution, 
especially among 
baseline light 
drinkers 
Strong 
30 
 
 
Peters, 2010 
(Peters and 
Hughes, 2010)   
USA Prospective 
cohort 
Daily cannabis users 
not trying to stop or 
reduce cannabis 
 
28 Consumption MWC, MCQ, CPQ, 
and PACS 
 
Cannabis 
abstinence 
Drinks per 
day 
Substitution Moderate 
Kadden, 2009 
(Kadden et al., 
2009) 
USA Prospective 
cohort 
Cannabis treatment 
seekers 
207 Consumption Time-line Follow-
Back (TLFB), 
Addiction Severity 
Index, Marijuana 
Problem Scale, 
Coping Strategies 
Scale 
Past 90 days 
cannabis 
frequency 
Indicator of 
increased 
(>10%) past 
90-day 
proportion 
days using 
alcohol, 
drinks per 
drinking day 
Neither Moderate 
Hughes, 2008 
(Hughes et al., 
2008)  
USA Prospective 
cohort 
Daily cannabis users 
trying to stop or 
reduce on their own 
19 Not specified Questionnaire for 
cannabis use and 
intentions to use 
 
Cannabis 
abstinence 
Alcohol use Neither Weak 
Copersino, 
2006 
(Copersino et 
al., 2006a) 
USA Prospective 
cohort 
Non-treatment seeking 
cannabis users 
104 Self-reported 
use 
Marijuana Quit 
Questionnaire 
None Self-
reported 
use of 
alcohol to 
relieve 
cannabis 
withdrawal 
during quit 
attempt 
 
Substitution: 
Some evidence to 
relieve 
withdrawal 
 
Weak 
Copersino, 
2006 
(Copersino et 
al., 2006b) 
USA 
 
 
 
 
Cross 
sectional 
survey 
Non-treatment seeking 
adult cannabis smokers 
 
104 Consumption Marijuana Quit 
Questionnaire 
Cannabis 
abstinence 
Alcohol use Substitution Weak 
31 
 
Budney, 2003 
(Budney et al., 
2003)  
USA 
 
 
 
Prospective 
cohort 
18 cannabis users; 12 
past users in parallel 
 
30 Not specified MWC, MCQ, Brief 
Symptom 
Inventory,  
Cannabis 
abstinence 
Alcohol use Neither Moderate 
Budney, 2001 
(Budney et al., 
2001)   
USA Prospective 
cohort 
Daily cannabis users 12 Not specified Substance use 
diary, MWC, the 
Brief Symptom 
Inventory, MCQ 
 
Cannabis 
abstinence 
Alcohol use Neither Weak 
Kouri, 2000 
(Kouri and 
Pope, 2000) 
USA Prospective 
cohort 
Current and former 
cannabis users 
60 Toxicological 14-item daily 
withdrawal diary, 
Hamilton 
Depression Rating 
Scale, Hamilton 
Anxiety Scale 
 
Cannabis 
withdrawal 
symptoms 
Changes in 
alcohol use 
Neither Moderate 
Stephens, 
2000 
(Stephens et 
al., 2000) 
USA 
 
 
 
 
Prospective 
cohort 
Cannabis treatment 
seekers 
291 Consumption Follow up 
questionnaires 
Past 90 days 
alcohol 
frequency 
Monthly 
cannabis 
frequency 
 
Weak 
complements 
Moderate 
Stephens, 
1994 
(Stephens et 
al., 1994) 
USA Prospective 
cohort 
Cannabis treatment 
seekers 
212 Consumption DAST Weekly 
alcohol use 
Past 90 days 
cannabis 
frequency 
Neither Moderate 
 
Alcohol cessation or reduction (4 studies) 
 
Subbaraman, 
2017 
(Subbaraman 
et al., 2017) 
USA 
 
 
 
 
 
Secondary 
analysis of 
RCT 
Newly alcohol-
abstinent alcohol-
dependant participants 
(COMBINE Study) 
1383 Consumption Follow-up 
medical 
assessments at 
week 8, 16, 26, 
52, and 68 
Cannabis use 
and quartiles 
of cannabis 
use 
Post 
treatment 
percentage 
of days 
abstinent, 
Drinks Per 
Drinking 
Day, and 
Weak evidence 
for 
complementarity 
Moderate 
32 
 
Percentage 
of Heavy 
Drinking 
Days 
 
Peters, 2012 
(Peters et al., 
2012)  
USA RCT 8-week RCT of 
naltrexone for alcohol 
use 
122 (18-
21 years 
old) 
Consumption Young Adult 
Consequence 
Questionnaire, 
The 
Contemplation 
Ladder, The 
Barrat Impulsivity 
Scale, Drinking-
Induced 
Disinhibition 
Scale, Medication 
Adherence 
Questionnaire 
 
Cannabis user Individual-
level alcohol 
use and 
related 
problems 
Neither Weak 
Aharonovich, 
2005 
(Aharonovich 
et al., 2005)   
USA Prospective 
cohort 
Inpatient 
psychiatric/substance 
abuse treatment 
250 Self-reported 
use 
Longitudinal 
Psychiatric 
Research 
Interview for 
Substance and 
Mental  
Disorders 
 
Post discharge 
cannabis use 
Alcohol use 
post 
treatment 
Complements Weak 
Mikuriya, 
2004 
(Mikuriya, 
2004) 
USA Longitudinal 
cohort study 
Seekers of physician’s 
approval to use 
cannabis for alcohol 
treatment 
92 Consumption Examination of 
medical records 
follow up 
interview 
indicator, 
alcohol 
Efficacy of 
treating 
alcoholism 
with 
cannabis 
 
Substitution Weak 
Rosenberg, 
1978 
Longitudinal 
Pre/post 
study 
USA Men experiencing 
difficulties with alcohol 
44 Consumption Not specified Cannabis or 
cannabis and 
disulfiram 
Alcohol use 
during 
Neither Moderate 
33 
 
(Rosenberg et 
al., 1978) 
alcohol 
treatment 
Abbreviations for measurement tool: MTF (Monitoring The Future Survey), MWC (Marijuana Withdrawal Checklist), MCQ (Marijuana Craving Questionnaire), CPQ (Cannabis Problems 
Questionnaire), Penn Alcohol Craving Scale 
 
 
Table 4. Economic relationship studies (ten studies) 
 
Paper 
 
 
Country 
 
 
Study design 
 
Population 
 
Sample size 
 
Measure 
Category 
 
 
Measurement 
tool 
 
Independent 
variable 
 
Dependent 
variable 
 
Conclusion 
 
Quality 
assessment 
 
General population studies (3 studies) 
 
Cameron, 
2001 
(Cameron 
and 
Williams, 
2001) 
Australia Cross 
sectional 
survey 
National 
Drug 
Strategy 
Household 
Survey 
(Australia) 
9,744 Consumption Australian 
National Drug 
Strategy’s 
Household 
Survey 
State-level 
cannabis 
decriminalisation 
indicator 
Individual-
level past 12 
months 
cannabis and 
alcohol use 
Both: 
Decriminalisation 
increases alcohol 
use suggesting 
complements, 
price effects 
suggest 
substitution 
 
Strong 
Saffer, 1999 
(Saffer and 
Chaloupka, 
1999a) 
USA Cross 
sectional 
survey 
National 
Household 
Survey on 
Drug Abuse 
49,802 Consumption National 
Household 
Survey on Drug 
Abuse 
State-level 
cannabis 
decriminalisation 
indicator 
Individual-
level alcohol 
frequency, 
cannabis use 
Both 
Complements for 
full sample, white 
males and blacks: 
substitutes for 
Native Americans 
and Hispanics 
 
Strong 
Saffer, 1998 
(Saffer and 
Chaloupka, 
1999)  
USA Cross 
sectional 
survey 
National 
Household 
Survey on 
Drug Abuse 
49,802 Consumption National 
Household 
Survey of Drug 
Abuse 
State-level 
alcohol and drug 
prices 
Individual-
level alcohol 
frequency, 
cannabis use 
Complements Strong 
34 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Young people studies (4 studies) 
 
 
Williams, 
2004 
(Williams et 
al., 2004) 
USA Cross 
sectional 
survey 
Harvard 
School of 
Public 
Health's 
College 
Alcohol 
Study (CAS) 
(1993, 1997, 
1999) 
 
15,479 
expands (Cameron 
2001) to 
polysubstance users 
& adds control for 
drunk driving 
Consumption Harvard School 
of Public 
Health's 
College Alcohol 
Study (CAS) 
 
State-level 
cannabis 
decriminalisation 
indicators, fines 
for drunk driving, 
price for cannabis 
and alcohol 
Individual-
level past 
year cannabis 
use 
Complements, 
especially among 
polysubstance 
users & males 
Strong 
Pacula, 
1998  
(Pacula, 
1998) 
USA Longitudinal 
panel 
National 
Longitudinal 
Survey of 
Youth (1979) 
8,008 Consumption National 
Longitudinal 
Survey of Youth 
State-level beer 
tax 
Individual-
level past 30 
days # drinks, 
# of times 
used 
cannabis 
 
Complement Strong 
Chaloupka, 
1997 
(Chaloupka 
and 
Laixuthai, 
1997) 
USA Cross 
sectional 
survey 
Monitoring 
the Future 
25,430 Consumption Monitoring the 
Future 
State-level 
cannabis 
decriminalisation 
indicator 
Individual-
level alcohol 
frequency, 
heavy 
drinking 
accidents 
 
Substitution Strong 
35 
 
Yamada, 
1996 
(Yamada et 
al., 1996) 
USA Cross 
sectional 
survey 
12th grade 
high school 
students in 
the 
academic 
year of 
1981/1982 
 
672 Consumption National 
Longitudinal 
Survey of Youth 
State-level liquor 
price / marijuana 
decriminalisation 
Individual-
level 
marijuana 
use / 
Individual-
level alcohol 
use 
Both Strong 
 
Drug user’s studies (2 studies) 
 
Cole, 2008 
(Cole et al., 
2008) 
UK Cross 
sectional 
survey 
Polydrug 
users who 
illegally use 
controlled 
drugs 
80 Monetary AUDIT, DAST-A, 
SDS, HADS, 
simulation 
purchase of 
alcohol and 
drugs 
 
Changes in the 
quality of 
cannabis 
Individual-
level 
purchase 
Substitution Weak 
Williams, 
2004 
(Williams 
and 
Mahmoudi, 
2004)  
Australia Cross 
sectional 
survey 
Australian 
National 
Drug 
Strategies 
Household 
Survey 
48,174 Consumption Australian 
National Drug 
Strategy’s 
Household 
Survey 
State-level 
cannabis 
decriminalisation 
indicator; 
cannabis price 
State-level 
past month & 
past year 
alcohol and 
cannabis 
frequency 
Complement Strong 
 
Other (1 study) 
 
Clements, 
2004 
(Clements, 
2004)  
Australia Economic 
analysis 
Australian 
Drug market 
NA Monetary Australian 
Bureau of 
Criminal 
Intelligence 
Changes in 
marijuana prices 
Alcohol 
consumption 
Substitution Unrated 
Abbreviations for measurement tool: AUDIT (Alcohol Use Disorder Identification Test), DAST-A (Drug Abuse Screening Test for Adolescents, SDS (Severity of Dependence Scale for cannabis), SDS 
(Hospital Anxiety and Depression Scale) 
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Table 5. Patterns of use studies (six studies) 
 
Paper 
 
 
Country 
 
 
Study 
design 
 
Population 
 
Sample 
size 
 
Measure 
Category 
 
 
Measurement 
tool 
 
Independent variable 
 
Dependent variable 
 
Conclusion 
 
Quality 
assessment 
 
General population studies (1 study) 
 
Choi, 2018 
(Choi et al., 
2018)  
USA Longitudinal 
panel 
PATH study 
(wave 1 and 2) 
respondents 
26,204 Consumption Population 
Assessment of 
Tobacco and 
Health Study 
(PATH) 
Past 12 months and 
30 days of frequency 
of cannabis use 
Past 12 months and 
30-day frequency of 
alcohol use 
Complements Moderate 
 
Young people studies (5 studies) 
 
Gripe, 2018 
(Gripe et al., 
2018)  
  
Sweden Cross 
sectional 
survey 
Swedish Council 
for Information 
on Alcohol and 
Other Drugs 
Survey 
population 
 
149,603 Consumption Swedish Council 
for Information on 
Alcohol and other 
Drugs Survey  
Individual-level 
alcohol use 
Individual-level 
cannabis use 
Neither Strong 
O’Hara, 
2016 
(O’Hara et 
al., 2016) 
USA Longitudinal 
cohort 
study 
College 
students 
876 Consumption COPE inventory. 
Daily diary study: 
2-3 weeks after 
baseline using an 
Quantity of daily 
drinks and overall 
alcohol 30-day use 
Evening cannabis use Complement Weak 
37 
 
online website to 
report last night 
cannabis and 
alcohol use each 
day for 30 days. 
 
Deza, 2015 
(Deza, 2015)   
USA Longitudinal 
panel 
National 
Longitudinal 
Survey of Youth 
1997 
 
8,984 Consumption National 
Longitudinal 
Survey of Youth 
(1997) 
State-level medical 
marijuana laws 
State-level traffic 
fatalities, alcohol and 
cannabis use 
Complement Moderate 
Pape, 2009 
(Pape et al., 
2009) 
Norway Cross 
sectional 
survey 
European 
School Project 
on Alcohol and 
Drugs 
 
16,813 Consumption Norwegian youth 
Survey and ESPAD 
None Proportion of 
cannabis/alcohol use 
occasions 
 
Complement Weak 
           
Hammer, 
1992 
(Hammer 
and Vaglum, 
1992) 
Norway Longitudinal 
cohort 
study 
Sample 
extracted from 
the 1985 
NSYPASW aged 
17-20 
1,997 Consumption National Survey of 
Youngs People 
Adjustment to 
School and Work 
(NSYPASW) 
Total past frequency 
of cannabis use and 
past year frequency 
of cannabis use 
Past four weeks and 
past year of alcohol 
use, quantity of 
alcohol use in the last 
drinking incident 
Complement 
in young 
groups and 
young adult 
females 
Weak 
Abbreviations for measurement tool: ESPAD (European School Survey on Alcohol and Other Drugs) 
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Table 6. Substitution practices studies 
 
Paper 
 
 
Country 
 
Study design 
 
Population 
 
Sample 
size 
 
Measure 
category 
 
Measurement tool 
 
Independent 
variable 
 
Dependent variable 
 
Conclusion 
 
Quality 
assessment 
 
Medical Cannabis Patients (5 studies) 
 
Lucas, 2017 
(Lucas and 
Walsh, 
2017)  
Canada Cross sectional 
survey 
Patients 
registered 
to purchase 
cannabis 
from Tilray 
271 Self-reported 
substitution 
Online 107-item 
questionnaire 
available in French 
and English 
Medical cannabis 
use 
Participants 
reporting 
substituting 
cannabis for 
prescription drugs, 
alcohol tobacco, or 
illicit drugs 
 
Substitution Weak 
Piper, 2017 
(Piper et al., 
2017)   
USA Cross sectional 
survey 
Members of 
dispensaries 
in New 
England 
1,513 Self-reported 
substitution 
Online survey; items 
on self-reporting 
substitution of 
cannabis for alcohol 
and other drugs 
 
Medical cannabis 
use 
Prevalence of self-
reported 
substitution of 
alcohol for cannabis 
Substitution Weak 
Lucas, 2016 
(Lucas et al., 
2016)  
USA Cross sectional 
survey 
Cannabis 
Access for 
Medical 
Purpose 
Survey 
(CAMPS) 
 
473 Self-reported 
substitution 
Cannabis access for 
Medical Purposes 
Survey (CAMPS) 
Medical cannabis 
use 
Prevalence of 
substituting 
cannabis for 
prescription drugs, 
alcohol tobacco, or 
illicit drugs 
 
Substitution Weak 
39 
 
Lucas, 2013 
(Lucas et al., 
2013)  
Canada Cross sectional 
survey 
Medical 
cannabis 
patients 
from 
dispensaries 
in British 
Columbia 
404 Self-reported 
substitution 
Adapted version of 
medical cannabis 
survey from Reiman, 
2009 
None Self-reported 
substitution of 
cannabis for alcohol 
Substitution Weak 
Reiman, 
2009 
(Reiman, 
2009)    
 
 
 
 
 
USA Cross sectional 
survey 
Medical 
cannabis 
patients 
from 
Berkeley 
Patient’s 
Group 
(BPG) 
350 Self-reported 
substitution 
Survey created by 
researcher with 
portions adapted from 
a Medical cannabis 
patient survey 
None Self-reported 
substitution of 
cannabis for alcohol 
Substitution Weak 
 
Cannabis users (1 study) 
 
Lau, 2015 
(Lau et al., 
2015) 
USA Qualitative 
study 
Baby 
Boomer 
marijuana 
users in San 
Francisco 
97 Interview Semi-structured in-
depth life history 
interview, 
questionnaire and 
health survey 
Recreational 
cannabis use 
Self-reported 
substitution of 
cannabis for 
prescription drugs, 
alcohol, tobacco, or 
illicit drugs as a 
harm reduction 
measure 
Substitution Moderate 
(Assessed using 
CASP Tool) 
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Table 7. “Other” studies 
 
Paper 
 
 
Country 
 
Study 
design 
 
Population 
 
Sample 
size 
 
Measure 
category 
 
Measurement 
tool 
 
Independent 
variable 
 
Dependent 
variable 
 
Conclusion 
 
Quality 
assessment 
Klimas, 2016 
(Klimas et al., 
2016) 
Canada Longitudinal 
prospective 
community-
based 
cohort 
 
Heroin users 357 Consumption Self-report and 
50.3 month 
follow up 
Enrolment in 
Methadone 
Maintenance 
Treatment 
Initiation of 
heavy drinking 
Complement Weak 
Subbaraman, 
2015  
(Subbaraman 
and Kerr, 
2015) 
USA Cross 
sectional 
survey 
Current 
drinkers from 
the National 
Alcohol Study 
(NAS) 2005 
and 2010 
8,626 Consumption National Alcohol 
Study (NAS) 
Current alcohol 
use 
Past 12 months 
cannabis use 
frequency, drunk 
driving, alcohol 
related social 
consequences, 
alcohol related 
harms 
 
Some evidence 
of 
complementarity 
in concurrent 
users 
Moderate 
Reiman, 2007 
(Reiman, 
2007)   
USA Cross 
sectional 
survey 
Medical 
cannabis 
patients 
130 Self-reported 
substitution 
Qualitative 
interview, 
adapted from of 
the RAND 36-
item Health 
survey, Patient 
Satisfaction  
Questionnaire III 
 
None Self-reported 
substitution of 
cannabis for 
alcohol and other 
drugs 
Substitution Weak 
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Alter, 2006 
(Alter et al., 
2006)  
USA Cross 
sectional 
survey 
Monitoring 
the Future, 
Midwest 
subsample 
11,542 Consumption Survey like 
Monitoring the 
future 
Perceived access 
and harms of 
alcohol and 
cannabis 
Individual-level 
past month 
alcohol and 
cannabis 
frequency 
Substitution Strong 
 
 
 
 
Table 8. Animal studies 
 
Paper 
 
 
Country 
 
Study design 
 
 
Population 
 
Sample size 
 
Measure 
category 
 
Measurement 
tool 
 
Independent 
variable 
 
Dependent 
variable 
 
Conclusion 
 
Quality 
assessment 
Filev, 2017 
(Filev et 
al., 2017) 
Brazil Longitudinal 
experimental 
DBA/2 Mice 84 Locomotor 
activity 
Sensitisation 
context for 15 
minutes (wooden 
box painted with 
white acrylic) 
Photo cannabinoid 
treatment (THC, 
THC+CBD, CBD) by 
injection 
Locomotor 
activity 
Substitution 
in THC and 
THC+CBD 
treatment, 
no effect for 
CBD 
treatment 
alone 
Low risk 
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